Complete remission seven years after treatment for metastatic malignant melanoma.

Abstract

BACKGROUND In this study, the authors identified seven-year survivors after completion of the French multicenter Phase II trial of fotemustine for the treatment of metastatic malignant melanoma. METHODS One hundred sixty-nine patients with metastatic malignant melanoma were included in this Phase II study. One hundred fifty-three patient records were… (More)

Topics

Cite this paper

@article{Petit1996CompleteRS, title={Complete remission seven years after treatment for metastatic malignant melanoma.}, author={Thomas Petit and J C Janser and Jacques Petit}, journal={Cancer}, year={1996}, volume={77 5}, pages={900-2} }